BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 22462566)

  • 1. Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a Consensus Panel.
    Smeenge M; Barentsz J; Cosgrove D; de la Rosette J; de Reijke T; Eggener S; Frauscher F; Kovacs G; Matin SF; Mischi M; Pinto P; Rastinehad A; Rouviere O; Salomon G; Polascik T; Walz J; Wijkstra H; Marberger M
    BJU Int; 2012 Oct; 110(7):942-8. PubMed ID: 22462566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel.
    Muller BG; Fütterer JJ; Gupta RT; Katz A; Kirkham A; Kurhanewicz J; Moul JW; Pinto PA; Rastinehad AR; Robertson C; de la Rosette J; Sanchez-Salas R; Jones JS; Ukimura O; Verma S; Wijkstra H; Marberger M
    BJU Int; 2014 Feb; 113(2):218-27. PubMed ID: 24215670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer.
    Washington SL; Bonham M; Whitson JM; Cowan JE; Carroll PR
    BJU Int; 2012 Jul; 110(1):50-5. PubMed ID: 22077660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal therapy in prostate cancer-report from a consensus panel.
    de la Rosette J; Ahmed H; Barentsz J; Johansen TB; Brausi M; Emberton M; Frauscher F; Greene D; Harisinghani M; Haustermans K; Heidenreich A; Kovacs G; Mason M; Montironi R; Mouraviev V; de Reijke T; Taneja S; Thuroff S; Tombal B; Trachtenberg J; Wijkstra H; Polascik T
    J Endourol; 2010 May; 24(5):775-80. PubMed ID: 20477543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling.
    Taverna G; Morandi G; Seveso M; Giusti G; Benetti A; Colombo P; Minuti F; Grizzi F; Graziotti P
    BJU Int; 2011 Dec; 108(11):1723-7. PubMed ID: 21756276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transrectal ultrasound (TRUS) and TRUS-biopsy accuracy in potential candidates for PRIAS active surveillance protocol.
    Lacetera V; Galosi AB; Cantoro U; Catanzariti F; Mazzaferro D; Cantoro D; Quaresima L; Conti A; Raquban R; Montironi R; Muzzonigro G
    Arch Ital Urol Androl; 2012 Dec; 84(4):272-5. PubMed ID: 23427762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal prostate cancer therapy.
    Onik G; Barzell W
    Urol Oncol; 2008; 26(5):506-10. PubMed ID: 18774464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Method of the connection HMRS and TRUS images--improvement of effectiveness transrectal core biopsy of the prostate].
    Lipczyński W
    Przegl Lek; 2012; 69(5):176-80. PubMed ID: 23050412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate carcinoma: transrectal US after cryosurgical ablation.
    Salomon CG; Kalbhen CL; Dudiak CM; Olson MC; Flisak ME; Flanigan RC
    Radiology; 1998 Feb; 206(2):533-8. PubMed ID: 9457209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of transrectal ultrasonography in prostate cancer.
    Ghai S; Toi A
    Radiol Clin North Am; 2012 Nov; 50(6):1061-73. PubMed ID: 23122038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.
    Eggener SE; Scardino PT; Carroll PR; Zelefsky MJ; Sartor O; Hricak H; Wheeler TM; Fine SW; Trachtenberg J; Rubin MA; Ohori M; Kuroiwa K; Rossignol M; Abenhaim L;
    J Urol; 2007 Dec; 178(6):2260-7. PubMed ID: 17936815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of focal prostatic lesions on transrectal ultrasound (TRUS) and the accuracy of TRUS to diagnose prostate cancer.
    Lee HY; Lee HJ; Byun SS; Lee SE; Hong SK; Kim SH
    Korean J Radiol; 2009; 10(3):244-51. PubMed ID: 19412512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
    BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transrectal ultrasonography for the detection and staging of carcinoma of the prostate.
    Smith JA
    J Clin Ultrasound; 1996 Oct; 24(8):455-61. PubMed ID: 8884522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image visibility of cancer to enhance targeting precision and spatial mapping biopsy for focal therapy of prostate cancer.
    Ukimura O; de Castro Abreu AL; Gill IS; Shoji S; Hung AJ; Bahn D
    BJU Int; 2013 Jun; 111(8):E354-64. PubMed ID: 23714647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer ablation with transrectal high-intensity focused ultrasound: assessment of tissue destruction with contrast-enhanced US.
    Rouvière O; Glas L; Girouin N; Mège-Lechevallier F; Gelet A; Dantony E; Rabilloud M; Chapelon JY; Lyonnet D
    Radiology; 2011 May; 259(2):583-91. PubMed ID: 21357522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of precise and multimodal MRI and TRUS in detection and management of early prostate cancer.
    Ukimura O
    Expert Rev Med Devices; 2010 Jul; 7(4):541-54. PubMed ID: 20583890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml.
    Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Hemal AK; Gupta NP
    NMR Biomed; 2007 Feb; 20(1):11-20. PubMed ID: 16894640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conventional transrectal ultrasound guided biopsy. Current role, indications, techniques and limitations].
    Areal Calama J
    Arch Esp Urol; 2015 Apr; 68(3):282-95. PubMed ID: 25948800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.